- Home
- THFF vs EBS Comparison
THFF vs EBS Comparison
Compare THFF & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THFF | EBS |
|---|---|---|
| Founded | 1984 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 721.3M | 663.3M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | THFF | EBS |
|---|---|---|
| Price | $60.46 | $12.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $60.00 | $15.00 |
| AVG Volume (30 Days) | 58.4K | ★ 812.2K |
| Earning Date | 02-03-2026 | 10-29-2025 |
| Dividend Yield | ★ 3.71% | N/A |
| EPS Growth | ★ 69.68 | N/A |
| EPS | ★ 6.25 | 1.35 |
| Revenue | $250,755,000.00 | ★ $788,900,000.00 |
| Revenue This Year | $33.24 | N/A |
| Revenue Next Year | $8.15 | $15.21 |
| P/E Ratio | $9.67 | ★ $9.15 |
| Revenue Growth | ★ 31.89 | N/A |
| 52 Week Low | $42.05 | $4.02 |
| 52 Week High | $65.79 | $13.41 |
Technical Indicators
Market Signals| Indicator | THFF | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 58.95 |
| Support Level | $64.27 | $12.02 |
| Resistance Level | $65.79 | $12.90 |
| Average True Range (ATR) | 1.26 | 0.50 |
| MACD | -0.64 | -0.05 |
| Stochastic Oscillator | 4.12 | 64.60 |
Price Performance
Historical ComparisonAbout THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.